Categories: News

HealthLynked Subsidiary ACO Health Partners LLC to Receive $2.4M in Medicare Shared Savings

NAPLES, FL / ACCESSWIRE / October 14, 2021 / HealthLynked Corp. (OTCQB:HLYK):

HealthLynked Corp’s Michael Dent and George O’Leary tell Proactive that its subsidiary ACO Health Partners LLC will receive $2.4 million in Medicare Shared Savings from the Centers for Medicare & Medicaid Services (CMS).

The company said the money represents a 213% increase over the $768,000 in shared savings that ACO Health Partners received the previous year. HealthLynked purchased ACO Health Partners in May 2020 and since has seen substantial increases in both shared savings and the number of attributed Medicare lives.

https://www.youtube.com/watch?v=Bnf67S8cfcI

About HealthLynked Corp.:

It is our mission to improve healthcare by the transfer of accurate medical information between patients and their healthcare providers, improving medical practice efficiency, increasing access to quality healthcare, and facilitating accurate medical diagnosis.

Contact:

George O’Leary
Chief Financial Officer
goleary@healthlynked.com
+1-(800)-928-7144, ext. 103

William Hayde
Capital Markets Strategist
bhayde@healthlynked.com
+1-(631)-403-4337

Investor Relations Contacts:
Jim Hock
Hanover International Inc.
jh@hanoverintlinc.com
+1-(760)-564-7400

SOURCE: HealthLynked Corp.

View source version on accesswire.com:
https://www.accesswire.com/667939/HealthLynked-Subsidiary-ACO-Health-Partners-LLC-to-Receive-24M-in-Medicare-Shared-Savings

Staff

Recent Posts

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

2 hours ago

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

2 hours ago

Adia Nutrition Inc. Recaps Transformative 2025: Explosive Growth, Strategic Focus, and Path to Nasdaq Uplisting

Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a…

2 hours ago

Changing Healthcare Trajectories With Positive Experiences

DaVita works with others in under-resourced communities to offer individualized health engagements, break down mistrust…

2 hours ago

Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On

PONTE VEDRA, FL / ACCESS Newswire / December 29, 2025 / Every industry has its…

2 hours ago

SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)

Contract Research Organization for the REGAL trial has informed the Company that 72 events have…

2 hours ago